Official journal of the Slovak Society of Cardiology,
Slovak Society of Hypertension and Slovak Association for Cardiac Arrhythmias

Cardiology Letters 2024, 33(1):5-12

Comment on 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension

Iveta ©imková1, Bibiana Kafková2, Juraj Podracký2
1 Klinika kardiológie a angiológie LF SZU a NÚSCH, a. s., Bratislava, Slovenská republika
2 I. kardiologická klinika LF UPJ© a VÚSCH, a. s., Koąice, Slovenská republika

Published: January 1, 2024  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
©imková I, Kafková B, Podracký J. Comment on 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Cardiology Letters. 2024;33(1):5-12.
Download citation

References

  1. Humbert M, Kovacs G, Hoeper M, Badagliacca R, Berger RMF, Brida M, et al. 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J 2022;43:36183731. https://doi.org/10.1093/eurheartj/ehac237 Go to original source...
  2. Rosenkranz S, Delcroix M, Giannakoulas G, Hoeper M, Kovacs G, Humbert M. The 'Ten Commandments' of the 2022 ESC/ ERS Guidelines for the diagnosis and treatment of pulmonary hypertension Eur Heart J 2023 44:792-793. Go to original source...
  3. Maron BA, Hess E, Maddox TM, Opotowsky AR, Tedford RJ, Lahm T, et al. Pulmonary vascular resistance and clinical outcomes in patients with pulmonary hypertension: a retrospective cohort study. Lancet Respir Med 2020;8:873-884. Go to original source...
  4. Lichtblau M, Titz A, Bahrampoori B, Schmiedeskamp M, Ulrich S. What changed after the 2022 guidelines for pulmonary hypertension? Eur J Internal Med 2023, https://doi.org/10.1016/j.ejim.2023.08.021 Go to original source...
  5. Grünig E, Benjamin N, Behr J, Skowasch D, Milger-Kneidinger K, Halank M, et al. The new European Guidelines for Pulmonary Hypertension with Updated Commentary of the PH-DACH Conference. A position paper of the German Society for Pneumology and Respiratory Medicine (DGP). Pneumologie 2023;77:852-853. Go to original source...
  6. Baumgartner H, De Backer J, Babu-Narayan SV, Budts W, Chessa M, Diller G-P, et al. 2020 ESC Guidelines for the management of adult congenital heart disease. The Task Force for the Management of ACHD of the ESC. Eur Heart J 2020; doi:10.1093/eurheartj/ehaa554 Go to original source...
  7. Konstantinides SV, Meyer G, Becattini C, Bueno H, Geersing GJ, Harjola VP, et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the ERS. Eur Heart J; 2019; doi/10.1093/eurheartj/ehz405. Go to original source...
  8. Hoeper MM, Gomez Sanchez MA, Humbert M, Pittrow D, Simonneau G, Gall H, et al. Riociguat treatment in patients with pulmonary arterial hypertension: Final safety data from the EXPERT registry. Resp Medicine, 2020, DOI: https://doi.org/10.1016/j.rmed.2020.106241 Go to original source...
  9. Jansa P, Kopeć G, Torbicki A, Sadushi-Kolici R, Campean JA, Halank M, Simkova I, et al. The risk profile change in patients with severe chronic thromboembolic pulmonary hypertension treated with subcutaneous treprostinil. Pulmonary Circulation, 2023;13:e12274, https://doi.org/10.1002/pul2.12274 Go to original source...
  10. Guarino D, Ballerini A, Manes A. Commentary. What changed after the 2022 guidelines for pulmonary hypertension? Eur J Internal Med 2023, https://doi.org/10.1016/j.ejim.2023.08.021 Go to original source...
  11. Humbert M, Sitbon O, Guignabert Ch, Savale L, Boucly A, GallantDewavrin M. Treatment of PAH: recent progress and look to the future. Lancet Respir Med 2023,11:804-819. Go to original source...